Menu
FM Ashkenazi meets with Cypriot FM Nikos Christodoulides

FM Ashkenazi meets with Cypriot FM …

FM Ashkenazi: Israel and ...

MFA hosts virtual conference on digital diplomacy during the corona crisis

MFA hosts virtual conference on dig…

Some 150 participants wil...

PM Netanyahu chairs Corona Cabinet meeting

PM Netanyahu chairs Corona Cabinet …

The goal of the policy is...

Israel marks Memorial Day for the fallen soldiers and victims of terrorism

Israel marks Memorial Day for the f…

Remembrance Day, Yom Hazi...

President Rivlin and FM Katz host reception for the diplomatic and consular corps in Israel

President Rivlin and FM Katz host r…

President Rivlin: Althoug...

Special Holy Fire ceremony held during the coronavirus outbreak

Special Holy Fire ceremony held dur…

The traditional Holy Fire...

PM Netanyahu addresses the ceremony marking Holocaust Martyrs' and Heroes' Remembrance Day

PM Netanyahu addresses the ceremony…

Prime Minister Benjamin N...

Holocaust Martyrs' and Heroes' Remembrance Day 20-21 April 2020

Holocaust Martyrs' and Heroes' Reme…

The official Opening Cere...

Briefing for foreign ambassadors on Coronavirus management and cooperation with the Palestinians

Briefing for foreign ambassadors on…

During the briefing, the ...

Yad L'Achim Opens Hotline for Assistance from Experienced Psychologists, Social Workers

Yad L'Achim Opens Hotline for Assis…

Confused? Under Pressure?...

Prev Next
A+ A A-
Booking.com

Teva Announces: President and CEO. Dr. Jeremy Levin steps down as President and CEO, Eyal Desheh, Teva's Group EVP & Chief Financial Officer, named interim President and CEO Featured

JERUSALEM, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its Board of Directors has agreed with Dr. Jeremy Levin that he will step down as President and Chief Executive Officer. The Board has named Eyal Desheh, Teva's Executive Vice President and Chief Financial Officer, to fill the role of President and Chief Executive Officer on an interim basis, effective immediately, and it has formed a committee that will promptly begin to search for a permanent successor. 

Dr. Phillip Frost, Chairman of the Board, stated “On behalf of the entire Board of Directors, I would like to thank Dr. Jeremy Levin for his meaningful contribution to Teva during the last two years. The Board and management team are fully committed to the implementation of Teva's strategy, including the development of new compounds, making strategic acquisitions, forming joint ventures and the planned acceleration of the Company’s cost reduction program.”

“Since I joined Teva, we have made tremendous progress in setting a new course for the Company,” said Dr. Jeremy Levin. "I wish the Company and its people, who I respect greatly, every success. I look forward to pursuing new opportunities where I can continue to apply my experience and contribute to the evolution of the global pharmaceutical industry.”

"I have full confidence in the ability of Teva's management and employees to achieve our goals and execute the strategy laid out for the Company,” said Eyal Desheh, who has served at Teva for over 12 years, including the last five as Chief Financial Officer. “My colleagues in Teva's management and I will continue to drive execution and results in full collaboration with our Board of Directors, for the benefit of our patients, shareholders, customers and employees."

As previously scheduled, Teva will report its third quarter 2013 financial results on October 31, 2013.
Last modified onMonday, 09 January 2017 15:10

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top

Sections

Jewish Traditions

About Us

Community

Cooperations

Follow Us